Symptom-centric view
Rash
Substances reporting Rash disproportionately — ranked by ROR.
showing 8 of 8
| Substance ↓ | ROR [95% CI] | Reports | Category | Label |
|---|---|---|---|---|
tretinoin Retin-A · Atralin | 2.6 [2.4–2.9] | 449 | injectables | new |
nicotinamide Niacinamide | 7.4 [6.6–8.3] | 324 | longevity | new |
| 2.4 [2.4–2.5] | 7,474 | algemeen | new | |
| 2.6 [2.5–2.6] | 12,424 | algemeen | new | |
| 6.5 [6.2–6.9] | 1,664 | algemeen | new | |
| 2.6 [2.5–2.6] | 12,441 | algemeen | new | |
| 5.2 [5.1–5.3] | 13,127 | algemeen | new | |
| 2.4 [2.2–2.6] | 757 | algemeen | new |
ROR = reporting odds ratio vs. the full FAERS corpus. A signal is not a cause. Source: openFDA (FAERS).